© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Tourmaline Bio, Inc. (TRML) shows an Average True Range (ATR) of 0.28 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 687.52K, indicating liquidity. These fundamental metrics provide insight into TRML's underlying financial health and market activity.
Tourmaline Bio, Inc. (TRML) technical indicators as of December 23, 2025: the SMA 20 is 0.16%, SMA 50 at 17.94%, and SMA 200 at 111.02%. The RSI 14 value is 89.35, suggesting its current momentum. These technical analysis signals help assess TRML's price trends and potential future movements.
Tourmaline Bio, Inc. (TRML) stock performance overview as of December 23, 2025: The 52-week high is $48.27 (currently -0.6% below), and the 52-week low is $11.56 (currently 315.05% above). Over the past year, TRML's performance is N/A, compared to the S&P 500's 10.56% change.
According to market data, Tourmaline Bio, Inc. (TRML) stock's recent performance metrics show that over the last month, TRML is 0.5%, with a Year-to-Date (YTD) performance of 136.59%. Over the past year, the stock has seen a N/A change. These figures summarize TRML's price movements across various periods, reflecting its historical returns.
According to current financial data, TRML stock's P/E (TTM) ratio is -13.97, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for TRML, including P/S (30816.28), P/B (4.77), and P/FCF (-14.28), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.